Downregulation of G2/mitotic-specific cyclinB1 triggers autophagy via AMPK-ULK1-dependent signal pathway in nasopharyngeal carcinoma cells.
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
30 01 2019
30 01 2019
Historique:
received:
22
11
2018
accepted:
14
01
2019
entrez:
1
2
2019
pubmed:
1
2
2019
medline:
5
6
2020
Statut:
epublish
Résumé
CyclinB1 is a regulatory protein involved in mitosis. Multiple lines of evidence indicate that cyclinB1 depletion constrains proliferation and induces apoptosis in human tumor cells. The cells become susceptible to suffer a critical situation when cyclinB1 is downregulated. Autophagy is a major intracellular degradation system that recycles nutrients, removes damaged organelles, and promotes cell survival under stressful conditions, whereas the role of autophagy in cyclinB1-deprived neoplastic cell as well as the underlying molecular mechanism remains obscure. Here we pioneeringly elaborated that specific knockdown of cyclinB1 triggered autophagy via AMPK-ULK1-dependent signal pathway through the elevation of ROS, rather than ATP in the cell lines of CNE-1 and CNE-2. Moreover, ROS scavengers demonstrated that the observed effect of cyclinB1 silencing on AMPK phosphorylation was ROS dependent. Additionally, double knockdown of AMPK and cyclinB1 evidently abrogated cyclinB1 silencing-induced autophagy. Summarily, this study first revealed that downregulation of cyclinB1 induced autophagy via AMPK-ULK1-dependent signal pathway, which represents a key step toward unveiling the mechanism how cell cycle checkpoint proteins regulate autophagy.
Identifiants
pubmed: 30700698
doi: 10.1038/s41419-019-1369-8
pii: 10.1038/s41419-019-1369-8
pmc: PMC6353984
doi:
Substances chimiques
AMP-Activated Protein Kinases
EC 2.7.11.31
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
94Références
Cancer Res. 1996 Sep 15;56(18):4159-63
pubmed: 8797586
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Cell. 2007 Dec 14;131(6):1137-48
pubmed: 18083103
Int J Cancer. 2005 Sep 10;116(4):520-5
pubmed: 15818617
Cell. 2011 Nov 11;147(4):728-41
pubmed: 22078875
Cell Rep. 2017 Oct 3;21(1):1-9
pubmed: 28978464
Nat Commun. 2017 Jun 27;8:15916
pubmed: 28653662
Nat Rev Clin Oncol. 2016 Jul;13(7):417-30
pubmed: 27030077
Ann N Y Acad Sci. 2006 Dec;1091:102-9
pubmed: 17341607
Nat Cell Biol. 2011 Feb;13(2):132-41
pubmed: 21258367
Oncogene. 2004 Jul 29;23(34):5843-52
pubmed: 15208674
Nat Rev Mol Cell Biol. 2009 Jul;10(7):458-67
pubmed: 19491929
Science. 2011 Jan 28;331(6016):456-61
pubmed: 21205641
Aging (Albany NY). 2013 Jul;5(7):515-30
pubmed: 24018842
Am J Clin Nutr. 2011 Apr;93(4):891S-6
pubmed: 21325438
J Cell Sci. 2004 Nov 1;117(Pt 23):5479-87
pubmed: 15509864
Cell. 2013 Jan 17;152(1-2):290-303
pubmed: 23332761
Free Radic Biol Med. 2009 May 15;46(10):1386-91
pubmed: 19268526
J Oral Pathol Med. 1999 Feb;28(2):77-81
pubmed: 9950254
J Cancer Res Clin Oncol. 1997;123(2):124-7
pubmed: 9030252
Clin Cancer Res. 2015 Nov 15;21(22):5037-46
pubmed: 26567363
Am J Pathol. 1997 Jan;150(1):15-23
pubmed: 9006317